{"id":"https://openalex.org/W75330741","doi":null,"title":"Induction of increased FDG uptake and loss of NIS expression by a VEGFR-2 inhibitor in FRTL-5 cells: An in-vitro flip-flop mechanism","display_name":"Induction of increased FDG uptake and loss of NIS expression by a VEGFR-2 inhibitor in FRTL-5 cells: An in-vitro flip-flop mechanism","publication_year":2010,"publication_date":"2010-05-01","ids":{"openalex":"https://openalex.org/W75330741","mag":"75330741"},"language":"en","primary_location":{"id":"mag:75330741","doi":null,"is_oa":false,"landing_page_url":"https://jnm.snmjournals.org/content/51/supplement_2/1098","pdf_url":null,"source":{"id":"https://openalex.org/S4210180780","display_name":"Journal of Nuclear Medicine","issn_l":"0161-5505","issn":["0161-5505","1535-5667","2159-662X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315767","host_organization_name":"Society of Nuclear Medicine and Molecular Imaging","host_organization_lineage":["https://openalex.org/P4310315767"],"host_organization_lineage_names":["Society of Nuclear Medicine and Molecular Imaging"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Nuclear Medicine","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056056907","display_name":"Olaf Prante","orcid":"https://orcid.org/0000-0003-0247-3656","observed_orcids":["https://orcid.org/0000-0003-0247-3656"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Olaf Prante","raw_affiliation_strings":["Friedrich-Alexander University, Erlangen, Germany"],"raw_orcid":"https://orcid.org/0000-0003-0247-3656","affiliations":[{"raw_affiliation_string":"Friedrich-Alexander University, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048660918","display_name":"Philipp Michael Klein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Philipp Klein","raw_affiliation_strings":["Friedrich-Alexander University, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Friedrich-Alexander University, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058272199","display_name":"Simone Maschauer","orcid":"https://orcid.org/0000-0002-6550-933X","observed_orcids":["https://orcid.org/0000-0002-6550-933X"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Simone Maschauer","raw_affiliation_strings":["Friedrich-Alexander University, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Friedrich-Alexander University, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031319152","display_name":"Mariusz W. Szkudlinski","orcid":"https://orcid.org/0000-0002-5656-2104","observed_orcids":["https://orcid.org/0000-0002-5656-2104"]},"institutions":[{"id":"https://openalex.org/I4210165119","display_name":"Trophogen (United States)","ror":"https://ror.org/05vga3150","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariusz W. Szkudlinski","raw_affiliation_strings":["Trophogen Inc., Rockville, MD"],"raw_orcid":"https://orcid.org/0000-0002-5656-2104","affiliations":[{"raw_affiliation_string":"Trophogen Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210165119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112067957","display_name":"Bruce D. Weintraub","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165119","display_name":"Trophogen (United States)","ror":"https://ror.org/05vga3150","country_code":"US","type":"company","lineage":["https://openalex.org/I4210165119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce D. Weintraub","raw_affiliation_strings":["Trophogen Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trophogen Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210165119"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077009005","display_name":"Torsten Kuwert","orcid":"https://orcid.org/0000-0001-5682-8139","observed_orcids":["https://orcid.org/0000-0001-5682-8139"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Torsten Kuwert","raw_affiliation_strings":["Friedrich-Alexander University, Erlangen, Germany"],"raw_orcid":"https://orcid.org/0000-0001-5682-8139","affiliations":[{"raw_affiliation_string":"Friedrich-Alexander University, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.01319519,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"51","issue":null,"first_page":"1098","last_page":"1098"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.8794000148773193,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.8794000148773193,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.0551999993622303,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.02539999969303608,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vegfr-2-inhibitors","display_name":"VEGFR-2 inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/fdg-uptake","display_name":"FDG uptake","score":0.8569999933242798},{"id":"https://openalex.org/keywords/sodium-iodide-symporter","display_name":"sodium iodide symporter","score":0.8069999814033508},{"id":"https://openalex.org/keywords/nis-expression","display_name":"NIS expression","score":0.6340000033378601},{"id":"https://openalex.org/keywords/radioiodine-uptake","display_name":"radioiodine uptake","score":0.7829999923706055},{"id":"https://openalex.org/keywords/flip-flop-mechanism","display_name":"flip-flop mechanism","score":0.7900000214576721},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7519999742507935},{"id":"https://openalex.org/keywords/differentiated-thyroid-cancer","display_name":"differentiated thyroid cancer","score":0.8820000290870667},{"id":"https://openalex.org/keywords/frtl-5-cells","display_name":"FRTL-5 cells","score":0.8889999985694885},{"id":"https://openalex.org/keywords/glut1","display_name":"GLUT1","score":0.7670000195503235},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7239999771118164},{"id":"https://openalex.org/keywords/su5416","display_name":"SU5416","score":0.8790000081062317},{"id":"https://openalex.org/keywords/iodide-uptake","display_name":"iodide uptake","score":0.35600000619888306},{"id":"https://openalex.org/keywords/glucose-uptake","display_name":"glucose uptake","score":0.4740000069141388}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7004439830780029},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.5422055125236511},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5279043316841125},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4209236204624176},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.39074191451072693},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3569134473800659},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32538530230522156},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31552815437316895},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15682268142700195},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14320772886276245},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.13883772492408752},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13762128353118896}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:75330741","doi":null,"is_oa":false,"landing_page_url":"https://jnm.snmjournals.org/content/51/supplement_2/1098","pdf_url":null,"source":{"id":"https://openalex.org/S4210180780","display_name":"Journal of Nuclear Medicine","issn_l":"0161-5505","issn":["0161-5505","1535-5667","2159-662X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315767","host_organization_name":"Society of Nuclear Medicine and Molecular Imaging","host_organization_lineage":["https://openalex.org/P4310315767"],"host_organization_lineage_names":["Society of Nuclear Medicine and Molecular Imaging"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Nuclear Medicine","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2258420361","https://openalex.org/W2612378225","https://openalex.org/W2288750848","https://openalex.org/W2068453322","https://openalex.org/W2740359737","https://openalex.org/W2169792450","https://openalex.org/W2073466816","https://openalex.org/W3176279241","https://openalex.org/W4280519905","https://openalex.org/W1993210723"],"abstract_inverted_index":{"1098":[0],"Objectives":[2],"Antiangiogenesis":[4],"therapy":[5,258,266],"could":[6,267],"be":[7,268],"beneficial":[8],"for":[9,25,68,145,249],"the":[10,36,44,202,245,272],"treatment":[11],"of":[12,15,30,38,48,97,152,181,247,259,274],"radioiodine-negative":[13],"metastases":[14],"differentiated":[16],"thyroid":[17,56,241,278],"carcinomas":[18],"(DTC).":[19],"FDG-PET":[20],"has":[21],"been":[22],"successfully":[23],"used":[24],"imaging":[26],"DTC.":[27],"The":[28,231],"aim":[29],"this":[31],"study":[32],"was":[33,64,91,99],"to":[34,93,161,167,271],"investigate":[35],"effects":[37],"a":[39,236],"VEGFR-2":[40,146,203,232],"inhibitor,":[41],"focussing":[42],"on":[43],"clinically":[45],"relevant":[46],"endpoints":[47],"radioiodide":[49,188,210,250,265],"uptake":[50,53,90,189,196,211,251],"and":[51,66,88,110,116,128,155,164,174,186,209,252],"FDG":[52,78,195,208,254],"in":[54,220,239,244,277],"rat":[55,240],"FRTL-5":[57,73,221],"cells.":[58],"Methods":[60],"N-(2-bromo-pyridin-4-yl)anthranyl-(4-chlorophenyl)amide":[62],"(IFOP)":[63],"synthesized":[65],"screened":[67],"tyrosine":[69],"kinase":[70],"affinities":[71],"(Invitrogen).":[72],"cells":[74,98,184,279],"were":[75,120,132],"incubated":[76],"with":[77,101,149,264],"(0.5MBq/mL,":[79],"1":[80],"h)":[81],"or":[82],"iodide-131":[83],"(18-37":[84],"kBq/mL,":[85],"10":[86],"min)":[87],"tracer":[89],"referred":[92],"protein":[94],"mass.":[95],"Pretreatment":[96],"performed":[100],"IFOP":[102,141,177,215,234,262],"(0-20":[103],"\u00b5M),":[104],"TR1401":[105],"(150":[106],"ng/mL,":[107],"TSH":[108],"analog),":[109],"IGF-1":[111],"(100":[112],"ng/mL).":[113],"Cell":[114],"proliferation":[115,180],"apoptosis":[117],"(caspase":[118],"3/7)":[119],"measured":[121],"by":[122,134,190,197],"bioluminescence":[123],"assays.":[124],"Glucose":[125],"carrier":[126],"(GLUT-1)":[127],"sodium-iodide":[129],"symporter":[130],"(NIS)":[131],"determined":[133],"Western":[135],"blot":[136],"analysis.":[137],"Results":[139],"revealed":[142],"high":[143],"affinity":[144,160],"(Ki=20nM)":[147],"combined":[148,263],"moderate":[150],"inhibition":[151],"cKIT,":[153],"VEGFR-1":[154],"VEGFR-3":[156],"(each":[157],"IC50=5\u00b5M),":[158],"low":[159,165],"EGFR":[162],"(>5\u00b5M),":[163],"potency":[166],"inhibit":[168],"PDGFR-A,":[169],"FGFR,":[170],"FLT-3,":[171],"IGF1R,":[172],"RET":[173],"src":[175],"(>5\u00b5M).":[176],"inhibited":[178],"VEGF-induced":[179],"human":[182],"endothelial":[183],"(IC50=289nM)":[185],"TR1401-induced":[187],"80\u00b123%":[191],"(IC50=554nM),":[192],"while":[193],"increasing":[194],"18-fold":[198],"(EC50=3.7\u00b5M).":[199],"In":[200],"comparison,":[201],"inhibitor":[204,233],"SU5416":[205],"decreased":[206],"both":[207],"under":[212],"identical":[213],"conditions.":[214],"completely":[216],"abolished":[217],"NIS":[218,275],"expression":[219,225,276],"cells,":[222,242],"whereas":[223],"GLUT-1":[224],"remained":[226],"constant.":[227],"Conclusions":[229],"induced":[235],"flip-flop":[237],"mechanism":[238],"resulting":[243],"loss":[246,273],"capability":[248],"increased":[253],"uptake.":[255],"Thus,":[256],"antiangiogenesis":[257],"DTC":[260],"using":[261],"hampered":[269],"due":[270]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}